The smartest Australian stocks to buy with $400 right now

Let's see why these shares are highly rated by brokers.

| More on:
A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

You don't need thousands of dollars to start investing in the share market. Even a modest sum like $400 can get you on the path to building wealth — as long as you choose quality companies with strong long-term growth potential.

If you're ready to put that $400 to work today, here are three Australian stocks that analysts think could make a smart starting point for a beginner or someone looking to top up their portfolio. They are as follows:

Life360 Inc. (ASX: 360)

For investors looking for strong growth, Life360 could be an Australian stock to buy. Best known for its family safety app, Life360 now boasts 83.7 million monthly active users and is generating huge revenue from them. In fact, revenue climbed 32% year over year in the March quarter to US$103.6 million.

The company has turned the corner on profitability, generating positive operating cash flow and growing its paid users at a rapid pace. With new features and monetisation opportunities on the horizon, Life360 could be a stock with multi-year upside.

Morgan Stanley thinks it could be a buy and has an overweight rating and $40.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another Australian stock that could be a buy is ResMed. It is the global leader in sleep apnoea and respiratory care devices.

This is a huge market to be in, with over 1 billion people estimated to suffer from sleep apnoea globally. And with the vast majority of these sufferers unaware of their condition, ResMed stands to benefit greatly as knowledge increases. The latter is being helped by devices like the Apple Watch, which is now able to diagnose sleep apnoea.

So, with a growth outlook stretching into the decades and a valuation that looks cheap compared to historical multiples, now could be a great time to invest.

The team at Macquarie certainly believes this is the case. The broker has an outperform rating and $48.00 price target on its shares.

Telstra Group Ltd (ASX: TLS)

A final Australian stock to consider buying with the $400 is telco giant Telstra.

Its outlook has become increasingly positive this year thanks to its new Connected Future 30 strategy which aims to expand its return on invested capital to 10% by FY 2030, alongside steady dividend growth and potential buybacks.

This new strategy went down well with analysts at Macquarie. So much so, it recently put an outperform rating and $5.28 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Life360 and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, and Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

two children squat down in the dirt with gardening tools and a watering can wearing denim overalls and smiling very sweetly.
Broker Notes

Broker tips this ASX penny stock to double

This penny stock could be set for significant growth.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

What does Macquarie think Goodman Group shares are worth?

Is it a good time to buy this blue chip stock? Let's find out.

Read more »

A woman looks at a mobile phone as various screens appear nearby.
Communication Shares

Why these experts think Telstra has a place in your portfolio

Telstra's dominant market position and disciplined execution mean it's an attractive share to own, a broker says.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Endeavour, ResMed, and Westpac shares

Let's see what analysts are saying about these big names.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

7 ASX 200 shares upgraded to strong buy ratings

Looking for investment inspiration?

Read more »

Two young male miners wearing red hardhats stand inside a mine and shake hands
Broker Notes

Macquarie tips 23% upside for resurgent ASX 200 copper stock riding the red metal's bull run

Macquarie expects more outperformance from this surging ASX 200 copper stock.

Read more »

A woman pulls her jumper up over her face, hiding.
Energy Shares

Is there a downside ahead for Origin Energy shares?

Here's what the broker expects over the next 12 months.

Read more »